ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.72%)Nav, as on 25-02-2025

  • Previous Nav

  • Net Change on 25-02-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option -6.75 -7.29 14.48 24.20 26.12 20.79
BSE Health Care - TRI -6.61 -9.15 10.67 19.98 23.65 15.26
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 14.48 24.20 26.12 1.93 4,917.81
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 6.14 19.78 23.47 1.82 8,160.74
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 11.57 23.84 24.40 1.94 3,521.93
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 12.05 22.29 24.77 1.91 3,197.52
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 9.62 18.35 23.59 1.94 2,652.24
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 7.48 20.13 22.34 2.16 1,211.73

Fund Holdings as on 31-January-2025

  • Sun Pharmaceutical Industries Ltd.

  • Cipla Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Divi's Laboratories Ltd.

  • Aurobindo Pharma Ltd.

  • Lupin Ltd.

  • Alkem Laboratories Ltd.

  • Zydus Lifesciences Ltd.

  • Gland Pharma Ltd.

  • Mankind Pharma Ltd

  • Apollo Hospitals Enterprise Ltd.

  • Pfizer Ltd.

  • SBI Life Insurance Company Ltd.

  • Astrazeneca Pharma India Ltd.

  • Biocon Ltd.

  • Windlas Biotech Ltd.

  • Syngene International Ltd.

  • Medi Assist Healthcare Services Ltd

  • Medplus Health Services Ltd

  • Advanced Enzyme Technologies Ltd.

  • Shilpa Medicare Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Thyrocare Technologies Ltd.

  • Senores Pharmaceuticals Ltd

  • FDC Ltd.

  • Fine Organic Industries Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Aarti Industries Ltd.

  • Aarti Drugs Ltd.

  • TREPS

  • Atul Ltd.

  • Blue Jet Healthcare Ltd.

  • Yatharth Hospital & Trauma Care Services Pvt Ltd

  • Fortis Healthcare Ltd.

  • Sanofi Consumer Healthcare India Ltd

  • Procter & Gamble Health Ltd.

  • Star Health & Allied Insurance

  • Emcure Pharmaceuticals Ltd.

  • Alivus Life Sciences Ltd.

  • Sun Pharma Advanced Research Co. Ltd

  • Aster DM Healthcare Ltd.

  • Laxmi Dental Ltd.

  • Unichem Laboratories Ltd.

  • Vinati Organics Ltd.

  • Cash Margin - Derivatives

  • Galaxy Surfactants Ltd.

  • Laxmi Organic Industries Ltd.

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Chemicals

  • Business Support

  • Insurance

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

  • Household & Personal Products

View More

  • Cash

  • Equity

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹4,917.81 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended down ₹-0.25(-0.72%)yesterday to ₹34.7.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100